This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: University of Illinois. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2014
Title: Pradip Raychaudhuri: Innovator in Tumor Cell Proliferation Inhibition
Introduction
Pradip Raychaudhuri is a notable inventor based in Oak Park, IL (US). He has made significant contributions to the field of cancer research, particularly in the area of tumor cell proliferation. With a total of 4 patents to his name, Raychaudhuri's work focuses on innovative methods and compositions that aim to inhibit the growth of tumor cells.
Latest Patents
Raychaudhuri's latest patents include groundbreaking inventions such as "Methods and compositions inhibiting tumor cell proliferation." This invention provides agents, compositions, and pharmaceutical methods for inhibiting tumor cell proliferation by targeting FoxM1B activity, expression, or nuclear localization in tumor cells. Another significant patent is titled "Methods of inhibiting tumor cell proliferation," which outlines methods for preventing tumor progression in animals by inhibiting FoxM1B activity. These inventions represent a crucial step forward in cancer treatment strategies.
Career Highlights
Pradip Raychaudhuri is affiliated with the University of Illinois, where he continues to advance his research in tumor biology. His work has garnered attention for its potential impact on cancer therapies, making him a respected figure in the scientific community.
Collaborations
Raychaudhuri has collaborated with esteemed colleagues such as Robert Costa and Vladimir Kalinichenko. These partnerships have further enriched his research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Pradip Raychaudhuri's contributions to the field of tumor cell proliferation inhibition highlight his dedication to advancing cancer research. His innovative patents and collaborations underscore the importance of continued research in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
